87 related articles for article (PubMed ID: 8458182)
1. Reviews of new drugs.
Miller JL
Clin Pharm; 1993 Apr; 12(4):306. PubMed ID: 8458182
[No Abstract] [Full Text] [Related]
2. How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process.
Binzak BA
Food Drug Law J; 2003; 58(1):103-27. PubMed ID: 12739592
[No Abstract] [Full Text] [Related]
3. Pediatric drug development in anesthesiology: an FDA perspective.
Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA
Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624
[No Abstract] [Full Text] [Related]
4. Clinical investigation of new animal drugs by veterinary practitioners.
Prater DA; Bertone JJ; Letonja T; Vaughn SD
J Am Vet Med Assoc; 1996 Jan; 208(2):190-4. PubMed ID: 8567369
[No Abstract] [Full Text] [Related]
5. Drive for drugs leads to baby clinical trials.
Nature; 2006 Mar; 440(7083):406-7. PubMed ID: 16554774
[No Abstract] [Full Text] [Related]
6. New clinical trials policy at FDA.
Vastag B
Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
[No Abstract] [Full Text] [Related]
7. FDA slow to encourage lupus drugs.
Webber D
Nat Biotechnol; 1999 Apr; 17(4):319. PubMed ID: 10207867
[No Abstract] [Full Text] [Related]
8. The FDA's drug review process: ensuring drugs are safe and effective.
Meadows M
FDA Consum; 2002; 36(4):19-24. PubMed ID: 12184298
[No Abstract] [Full Text] [Related]
9. Clinical trials. New rule triggers debate over best way to test drugs.
Couzin J
Science; 2003 Mar; 299(5613):1651-3. PubMed ID: 12637715
[No Abstract] [Full Text] [Related]
10. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.
Meyerhoff A
Clin Infect Dis; 1999 Jan; 28(1):42-8; discussion 49-51. PubMed ID: 10028069
[TBL] [Abstract][Full Text] [Related]
11. The United States Food and Drug Administration and the end of antibiotics.
Shlaes DM; Moellering RC
Clin Infect Dis; 2002 Feb; 34(3):420-2. PubMed ID: 11774094
[No Abstract] [Full Text] [Related]
12. FDA evaluates accelerated approval process. Food and Drug Administration.
Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
[TBL] [Abstract][Full Text] [Related]
13. The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval process.
Roden DM; Temple R
Circulation; 2005 Apr; 111(13):1697-702. PubMed ID: 15811869
[No Abstract] [Full Text] [Related]
14. Beyond the lab in biotech. With so many drugs in trial, new jobs are opening up.
Carmichael M
Newsweek; 2002 Sep; 140(13):53. PubMed ID: 12375414
[No Abstract] [Full Text] [Related]
15. Can single-patient investigational new drug studies hurry slow trains to the fast track?
Chenoweth D
Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
[TBL] [Abstract][Full Text] [Related]
16. The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agents.
Powers JH; Ross DB; Brittain E; Albrecht R; Goldberger MJ
Clin Infect Dis; 2002 Mar; 34(6):879-81. PubMed ID: 11850875
[No Abstract] [Full Text] [Related]
17. Pregnancy and pills. New research finds prescriptions may be safer than you think.
Schultz S
US News World Rep; 1999 Apr; 126(13):64-6. PubMed ID: 10351523
[No Abstract] [Full Text] [Related]
18. A critical tipping point.
Zuckerman MB
US News World Rep; 2002 Apr; 132(13):72. PubMed ID: 11993366
[No Abstract] [Full Text] [Related]
19. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
Schultheis LW; Rappaport BA
Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
[No Abstract] [Full Text] [Related]
20. The FDA's new oncology office.
Pazdur R
Clin Adv Hematol Oncol; 2005 Aug; 3(8):612-3. PubMed ID: 16167044
[No Abstract] [Full Text] [Related]
[Next] [New Search]